GlassScriptPhysician profile
Jessica Espinosa
NPI 1063930907
$3,001.24
in general payments reported to CMS, 2019-2025
17 companies · $778 in 2025
The $778 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.92 · 2022: $128 · 2023: $816 · 2024: $1,252 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,845.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $706.86 | 2023-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $465.86 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Mirum Pharmaceuticals, INC. | $327.13 | 2023-2025 | Livmarli |
| Genzyme Corporation | $238.14 | 2023-2025 | |
| Abbvie INC. | $195.59 | 2023-2025 | |
| Sandoz INC. | $177.93 | 2023-2025 | Hyrimoz |
| Qol Medical, LLC | $161.24 | 2023-2024 | Sucraid, Sucraid |
| Sanofi Pasteur INC. | $156.32 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $152.23 | 2024-2025 | Bylvay |
| Glaxosmithkline, LLC. | $128.43 | 2022 | |
| Janssen Biotech, INC. | $85.69 | 2024-2025 | Stelara, Tremfya |
| Nestle Healthcare Nutrition INC. | $59.48 | 2023 | |
| Biocon Biologics INC | $37.90 | 2024 | Hulio |
| Aimmune Therapeutics, INC. | $31.87 | 2025 | Zenpep |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.71 | 2023-2024 | Cyltezo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.92 | 2021 | |
| Organon LLC | $17.94 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Espinosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.